Nantahala Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001472322

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2026 · 153 positions · Total reported value $2.18B · Top-10 concentration 29.0% · Updated 2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

Turnover: 34.3% · 25 new · 19 cut · 13 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.9% · vs SPY -5.1% · Prev Value $2.49B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.3% · vs SPY -4.5% · Latest Value $2.18B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Nantahala Capital Management, LLC disclosed 153 equity positions with a combined reported value of $2.18B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 29.0% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were XBI ($110.38M), BVS ($87.52M), TBBK ($70.57M). By sector, the heaviest allocations are Health Care 59.6%, Consumer Discretionary 16.8%. Versus the prior quarter, allocation shifted toward Health Care (+8.6pp), Financials (+4.6pp) and away from Industrials (-0.9pp), Other (-17.1pp).

Versus the prior quarter, Nantahala Capital Management, LLC opened 25 new positions, trimmed 19 and fully exited 13, a turnover rate of 34.3% of positions. The portfolio's overlap with the prior quarter was 77% of names.

The largest new positions opened in Q3 2026 were KRE ($69.44M), RARE ($35.16M), DLB ($29.39M).

Of the 13 positions fully exited versus the prior quarter, the largest were ITGR ($10.40M), AMLX ($8.74M), QURE ($7.44M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • KRE SPDR SERIES TRUST · $69.44M
  • RARE ULTRAGENYX PHARMACEUTICAL IN · $35.16M
  • DLB DOLBY LABORATORIES INC · $29.39M
  • VRDN VIRIDIAN THERAPEUTICS INC · $16.47M
  • RACC RESEARCH ALLIANCE CORP III · $11.91M
  • ATOS ATTOVIA THERAPEUTICS INC · $9.62M
  • ENTX ENTERA BIO LTD · $8.74M
  • DYN DYNE THERAPEUTICS INC · $6.16M

Fully Exited (vs previous quarter)

  • ITGR INTEGER HLDGS CORP · prev qtr: $10.40M
  • AMLX AMYLYX PHARMACEUTICALS INC · prev qtr: $8.74M
  • QURE UNIQURE NV · prev qtr: $7.44M
  • TRAX FIRST TRACKS BIOTHERAPEUTICS · prev qtr: $5.03M
  • RLYB RALLYBIO CORP · prev qtr: $3.01M
  • TRDA ENTRADA THERAPEUTICS INC · prev qtr: $2.21M
  • ALXO ALX ONCOLOGY HLDGS INC · prev qtr: $1.55M
  • BRCC BRC INC CL A · prev qtr: $1.40M

Insider Transactions (Form 4)

Latest Nantahala Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Nantahala Capital Management, LLC is an SEC-registered 13F filer based in New Canaan, CT, United States. As of Q2 2026 it reported 141 US equity positions with a combined value of $2.49B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW CANAAN, CT, United States
  • SEC registration: 801-72481 (status: Approved), registered 2011-06-24
  • Regulatory AUM (Form ADV): $3.11B as of 2026-09-14
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: nantahalapartners.com

Portfolio Structure

  • 141 positions · $2.49B reported value (Q2 2026)
  • Top 10 holdings = 43.8% of reported value
  • Largest position: IWM (ISHARES TR) at 24.1%
  • Average position size: $17.65M

Sector Tilt

  • Health Care 51.0%
  • Consumer Discretionary 14.7%
  • Financials 2.5%
  • (classified holdings cover 71% of value)

Quarterly Activity

  • Q2 2026: 24 new, 23 added, 38 reduced, 20 exited
  • 56 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 59.6%
Financials 7.1%
Technology 1.9%
Materials 0.8%
Other 11.7%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 700.00K $110.38M 5.07%
5.07%
Add
2 6.42M $87.52M 4.02%
4.02%
Add
3 1.47M $70.57M 3.24%
3.24%
Add
4 1.00M $69.44M 3.19%
3.19%
New
5 800.00K $69.06M 3.17%
3.17%
Hold
6 6.24M $49.96M 2.29%
2.29%
Add
7 9.04M $45.13M 2.07%
2.07%
Add
8 875.51K $45.08M 2.07%
2.07%
Reduce
9 2.12M $42.61M 1.96%
1.96%
Reduce
10 1.07M $41.23M 1.89%
1.89%
Add
11 140.30K $40.86M 1.88%
1.88%
Add
12 1.17M $40.71M 1.87%
1.87%
Add
13 7.14M $36.83M 1.69%
1.69%
Add
14 5.51M $36.17M 1.66%
1.66%
Hold
15 2.34M $35.16M 1.61%
1.61%
New
16 223.00K $33.81M 1.55%
1.55%
Hold
17 2.14M $32.84M 1.51%
1.51%
Add
18 6.91M $32.20M 1.48%
1.48%
Add
19 220.40K $31.26M 1.44%
1.44%
Add
20 500.00K $29.39M 1.35%
1.35%
New
21 440.56K $28.27M 1.30%
1.30%
Add
22 85.00K $28.27M 1.30%
1.30%
Hold
23 1.14M $26.26M 1.21%
1.21%
Hold
24 2.59M $25.98M 1.19%
1.19%
Add
25 4.80M $25.92M 1.19%
1.19%
Add
26 733.68K $25.61M 1.18%
1.18%
Add
27 6.58M $24.33M 1.12%
1.12%
Add
28 68.39M $24.29M 1.11%
1.11%
Hold
29 11.21M $24.11M 1.11%
1.11%
Add
30 3.81M $23.91M 1.10%
1.10%
Add
31 31.14K $23.61M 1.08%
1.08%
Reduce
32 1.73M $22.88M 1.05%
1.05%
Hold
33 1.25M $22.65M 1.04%
1.04%
Add
34 1.85M $22.41M 1.03%
1.03%
Add
35 4.57M $22.12M 1.01%
1.01%
Add
36 1.96M $21.54M 0.99%
0.99%
Add
37 2.76M $21.44M 0.98%
0.98%
Reduce
38 293.03K $20.32M 0.93%
0.93%
Add
39 198.75K $19.68M 0.90%
0.90%
Add
40 1.75M $19.40M 0.89%
0.89%
Add
41 2.24M $17.82M 0.82%
0.82%
Add
42 931.64K $17.78M 0.82%
0.82%
Add
43 662.90K $17.66M 0.81%
0.81%
Add
44 707.14K $17.64M 0.81%
0.81%
Add
45 2.10M $17.50M 0.80%
0.80%
Add
46 689.84K $17.34M 0.80%
0.80%
Reduce
47 13.87M $17.06M 0.78%
0.78%
Add
48 1.49M $16.99M 0.78%
0.78%
Add
49 1.68M $16.78M 0.77%
0.77%
Add
50 1.20M $16.47M 0.76%
0.76%
New

FAQ

What did Nantahala Capital Management, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Nantahala Capital Management, LLC reported 153 equity positions worth $2.18B in aggregate; its largest disclosed positions were XBI ($110.38M), BVS ($87.52M), TBBK ($70.57M).

How large is Nantahala Capital Management, LLC's portfolio?

Nantahala Capital Management, LLC reported $2.18B of long equity holdings across 153 positions as of 2026-Q3. Top-10 holdings account for 29.0% of reported value.

What is Nantahala Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/nantahala-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →